2022
DOI: 10.1016/j.bios.2021.113802
|View full text |Cite
|
Sign up to set email alerts
|

Recombinase polymerase amplification in minimally buffered conditions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2022
2022
2025
2025

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(8 citation statements)
references
References 23 publications
0
8
0
Order By: Relevance
“…M: DL5000 DNA marker; NC: negative control; 1-8: plasmid concentration ranges from 2.35×10 5 pg/mL-2.35×10 -2 pg/mL. many researchers have conducted studies regarding the optimization of this method, including buffered conditions, specificity enhancement, stirred conditions, and additional methods of detection such as RPA combined with LFD (Moody et al, 2016;Luo et al, 2019;Tomar et al, 2022). It is worth noting that combination of RPA with the latest CRISPR technology has been applied to various bioassay fields (Patchsung et al, 2020;Meng et al, 2021;Jiang H.J.…”
Section: Discussionmentioning
confidence: 99%
“…M: DL5000 DNA marker; NC: negative control; 1-8: plasmid concentration ranges from 2.35×10 5 pg/mL-2.35×10 -2 pg/mL. many researchers have conducted studies regarding the optimization of this method, including buffered conditions, specificity enhancement, stirred conditions, and additional methods of detection such as RPA combined with LFD (Moody et al, 2016;Luo et al, 2019;Tomar et al, 2022). It is worth noting that combination of RPA with the latest CRISPR technology has been applied to various bioassay fields (Patchsung et al, 2020;Meng et al, 2021;Jiang H.J.…”
Section: Discussionmentioning
confidence: 99%
“…A recent study by Tomar et al initially investigated the mechanism of pH changes in RPA assays and provided a valuable guide for the in-depth study of RPA. 15 Additionally, clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein (Cas) systems consisting of guide RNA and Cas protein have become increasingly widespread for in vitro diagnostics. Since the sensitivity provided by CRISPR/Cas systems does not meet the detection needs for specific targets, such as the infectious diseases discussed here, the combination of CRISPR/Cas systems and nucleic acid amplification has become an important trend to improve analytical performance further, and has been applied to various detection platforms like microfluidics and biosensors.…”
Section: A Brief Overview Of Detection Methodsmentioning
confidence: 99%
“…A typical example includes the use of nanomaterial or enzyme-based post-amplication means. [14][15][16] But the preparation of nanoprobes or enzyme-labeling complicates the assay process and also, the large quantities of reagents introduced might easily interfere with the assay reliability. Alternatively, some DNA-based isothermal amplication strategies, for example, rolling circle amplication (RCA), loopmediated isothermal amplication (LAMP), helicase dependent amplication (HDA), recombinase polymerase amplication (RPA), and strand displacement amplication (SDA), are popular for sensitivity improvement.…”
Section: Introductionmentioning
confidence: 99%